MarketPeel
Insider Trading Intelligence
SA

Salomon Azoulay

MBX
CHIEF MEDICAL OFFICER · MBX BIOSCIENCES, INC. · CIK 0002030246
FILING MIX · LIFETIME73%/27%
BUYS
8
SELLS
3
TOTAL VALUE
$3.51M
COMPANIES
1
ACTIVE SINCE
Sep 2024
HOLDINGS NOW
29,772
AVG SELL PX
$38.33
TRADE KIND
SHOWING 11 / 11
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizons · 15 pending
Forward-return performance of every backtestable P/S trade by Salomon Azoulay, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+66.67%-4.07%+0.81%-4.88%-14.32%
14d3+100.00%-16.73%
30d3+100.00%-18.87%+1.04%-19.91%-25.98%
60d3(3 pending)
90d3(3 pending)
180d3(3 pending)
1y3(3 pending)
2y3(3 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
MBX · 29,772 shares · as of May 8, 2026
048,63597,270145,905194,54020252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 8 buys / 3 sellsCOVERAGE · 8 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
MBX
MBX BIOSCIENCES, INC.
PURCHASE
Chief Medical Officer
15,003$16.00$240.0K29,772May 8, 2026May 11, 2026View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
Chief Medical Officer
15,00330,008May 8, 2026May 11, 2026View →
MBX
MBX BIOSCIENCES, INC.
SALE10b5-1
10b5-1 plan
55,000$38.38$2.11M14,769May 8, 2026May 11, 2026View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
Chief Medical Officer
55,000194,540May 8, 2026May 11, 2026View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
Chief Medical Officer
55,000$10.46$575.3K69,769May 8, 2026May 11, 2026View →
MBX
MBX BIOSCIENCES, INC.
SALE10b5-1
10b5-1 plan
15,003$38.30$574.6K14,769May 8, 2026May 11, 2026View →
MBX
MBX BIOSCIENCES, INC.
SALE
Chief Medical Officer
231$29.54$6.8K14,769May 6, 2026May 8, 2026View →
MBX
MBX BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
70,00070,000Feb 2, 2026Feb 3, 2026View →
MBX
MBX BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
15,00015,000Feb 2, 2026Feb 3, 2026View →
MBX
MBX BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
90,00090,000Feb 3, 2025Feb 5, 2025View →
MBX
MBX BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
45,01145,011Sep 12, 2024Sep 13, 2024View →
Other insiders · MBX
Loading peer insiders…
About this filer
CIK 0002030246
ROLE
Chief Medical Officer
PRIMARY
MBX
COMPANIES
1
ACTIVE SINCE
Sep 2024
MARKETPEEL · /INSIDER/0002030246DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback